Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2013
Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeJoshua Lukenbill, Lisa Rybicki, Mikkael A Sekeres, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation RecipientsReema R Mathanda, Betty K Hamilton, Lisa Rybicki, et al.
Heart (British Cardiac Society)|August 8, 2025
Cardiovascular disease in Sickle cell: mechanisms, diagnostics and therapeutic advancesElio Haroun, Ankit Agrawal, Aro Daniela Arockiam, et al.
American Journal of Hematology|April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomesMayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
The New England Journal of Medicine|April 3, 2026
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell DiseaseRabi Hanna, Haydar Frangoul, Luis Pineiro, et al.
Blood Advances|September 19, 2019
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantationBetty K Hamilton, Lisa A Rybicki, David Grove, et al.
Human Molecular Genetics|May 20, 2022
A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndromeSiddharth Srivastava, Booil Jo, Bo Zhang, et al.
Transplantation and Cellular Therapy|April 29, 2023
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 SubstudyPaul Szabolcs, Roei D Mazor, Dima Yackoubov, et al.
Pageof 8